Evidence map›Paper›PMID 31216022›Full record

ArticleNucleic acids research2019

XAB2 depletion induces intron retention in POLR2A to impair global transcription and promote cellular senescence.

Shuai Hou, Dajun Qu, Yue Li, Baohui Zhu, Dapeng Liang, Xinyue Wei, Wei Tang, Qian Zhang, Jiaojiao Hao, Wei Guo and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. USP10 Inhibits Ferroptosis via Deubiquinating POLR2A in Head and Neck Squamous Cell Carcinoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Shuai HouInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Dajun QuInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Yue LiBreast Disease and Reconstruction Center, Breast Cancer Key Lab of Dalian, Second Affiliated Hospital, Dalian Medical University, Dalian, China.
Baohui ZhuInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Dapeng LiangInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Xinyue WeiInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Wei TangSchool of Life Science and Technology, ShanghaiTech University, Shanghai, China.
Qian ZhangInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Jiaojiao HaoInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Wei GuoInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Weijie WangInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Siqi ZhaoInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Qi WangInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Sikandar AzamInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Misbah KhanInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Haidong ZhaoBreast Disease and Reconstruction Center, Breast Cancer Key Lab of Dalian, Second Affiliated Hospital, Dalian Medical University, Dalian, China.
Liye ZhangSchool of Life Science and Technology, ShanghaiTech University, Shanghai, China.
Haixin LeiInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Dalian Medical University · CNSecond Affiliated Hospital of Dalian Medical University · CNShanghaiTech University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

XAB2 is a multi-functional protein participating processes including transcription, splicing, DNA repair and mRNA export. Here, we report POLR2A, the largest catalytic subunit of RNA polymerase II, as a major target gene down-regulated after XAB2 depletion. XAB2 depletion led to severe splicing defects of POLR2A with significant intron retention. Such defects resulted in substantial loss of POLR2A at RNA and protein levels, which further impaired global transcription. Treatment of splicing inhibitor madrasin induced similar reduction of POLR2A. Screen using TMT-based quantitative proteomics identified several proteins involved in mRNA surveillance including Dom34 with elevated expression. Inhibition of translation or depletion of Dom34 rescued the expression of POLR2A by stabilizing its mRNA. Immuno-precipitation further confirmed that XAB2 associated with spliceosome components important to POLR2A expression. Domain mapping revealed that TPR motifs 2-4 and 11 of XAB2 were critical for POLR2A expression by interacting with SNW1. Finally, we showed POLR2A mediated cell senescence caused by XAB2 deficiency. Depletion of XAB2 or POLR2A induced cell senescence by up-regulation of p53 and p21, re-expression of POLR2A after XAB2 depletion alleviated cellular senescence. These data together support that XAB2 serves as a guardian of POLR2A expression to ensure global gene expression and antagonize cell senescence.

Indexed as

Transcription, GeneticCell LineCell Line, TumorCellular SenescenceDNA-Directed RNA PolymerasesHEK293 CellsHeLa CellsHumansIntronsRNA InterferenceRNA, MessengerRNA SplicingRNA Splicing FactorsTranscription FactorsTumor Suppressor Protein p53DNA-Directed RNA PolymerasesPOLR2A RNA polymerase, humanRNA, MessengerRNA Splicing FactorsTranscription FactorsTumor Suppressor Protein p53XAB2 protein, human

Identifiers

PMID31216022
PMCPMC6735682
OpenAlexW2953149600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.